2019
DOI: 10.1111/all.13938
|View full text |Cite
|
Sign up to set email alerts
|

Forced oscillation technique as method to document and monitor the efficacy of mepolizumab in treating severe eosinophilic asthma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 11 publications
1
9
0
Order By: Relevance
“…One study has attempted to determine whether oscillometry could distinguish any benefit of small versus large particle size ICS therapy based on peripheral versus central airway obstruction, respectively; however, this study only looked at the differential treatment effect on symptoms, not oscillometry, and used an arbitrary oscillometric definition of peripheral airway function [83]. Oscillometric indices are also sensitive to improvements in asthma in response to mepolizumab therapy [84]. These findings suggest an important role of oscillometry in identifying and monitoring treatment responses in asthma, complementary to traditional spirometry.…”
Section: Treatment Responses In Asthmamentioning
confidence: 99%
“…One study has attempted to determine whether oscillometry could distinguish any benefit of small versus large particle size ICS therapy based on peripheral versus central airway obstruction, respectively; however, this study only looked at the differential treatment effect on symptoms, not oscillometry, and used an arbitrary oscillometric definition of peripheral airway function [83]. Oscillometric indices are also sensitive to improvements in asthma in response to mepolizumab therapy [84]. These findings suggest an important role of oscillometry in identifying and monitoring treatment responses in asthma, complementary to traditional spirometry.…”
Section: Treatment Responses In Asthmamentioning
confidence: 99%
“…For benralizumab, Mathur et al found several indicators of enhanced response of the drug in two phase III trials in patients with elevated blood eosinophil counts, decreased lung function, long‐term oral corticosteroid use, and nasal polyposis 170 . In a small prospective study, Antonicelli et al showed that forced oscillation technique (a noninvasive method that provides information of the degree of obstruction of the respiratory system) could detect specific mepolizumab‐induced changes in peripheral airway function in patients undergoing treatment for severe eosinophilic asthma 171 …”
Section: Novel Treatments Driven By Asthma Endotypesmentioning
confidence: 99%
“…IOS-defined SAD may be modified by biologics, and particularly antiIL-5 monoclonal antibody mepolizumab was able to improve lung ventilation heterogeneity indexes in subjects with severe asthma after treatment [ 119 , 120 ]. Antonicelli and colleagues evaluated the role of FOT in monitoring the effects of mepolizumab treatment in severe eosinophilic asthma, which correlated with both eosinophil counts and asthma control scores [ 121 ]. Controlling eosinophilic bronchitis with anti-T2 therapies improves ventilation defects, measured by inhaled gas MRI, in adults with prednisone-dependent asthma [ 122 ].…”
Section: Introductionmentioning
confidence: 99%